Journal of Clinical Endocrinology & Metabolism, Vol 52, 982-987, Copyright © 1981 by Endocrine Society

ARTICLES

Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion

Y Harano, S Ohgaku, K Kosugi, H Yasuda, T Nakano, M Kobayashi, H Hidaka, K Izumi, A Kashiwagi and Y Shigeta

Insulin sensitivity has been determined in primary nonobese diabetics and subjects with borderline glucose intolerance by a newly devised technique using glucose, insulin, and somatostatin infusion. Insulin sensitivity for glucose utilization was decreased in both adult- and juvenile-onset diabetics. Eight out of 88 diabetics had normal insulin sensitivty and were free from microvascular complications. In lean subjects with borderline glucose intolerance, insulin sensitivity was decreased, although an overlap with normal was noted. All obese subjects with borderline glucose intolerance had reduced insulin sensitivity. An inverse relationship was observed between insulin sensitivity and fasting plasma glucose (FPG), and a significant correlation was observed between FPG and steady state plasma glucose levels (SSPG; r = 0.57; P less than 0.001). Improvement of diabetic control in eight diabetics with sulfonylureas decreased SSPG in all (P less than 0.05), although normalization of SSPG was observed in only one. These results indicate that decreased sensitivity of insulin for peripheral glucose utilization may play an important role in the pathogenesis of diabetes. Elevated FPG levels reflect the presence of decreased insulin sensitivity in diabetes mellitus. Although decreased sensitivity is difficult to normalize, it can be enhanced by improving the diabetic control. An effort to maintain or enhance tissue insulin sensitivity in diabetes mellitus may be more important than attempts to stimulate the deteriorating pancreatic beta-cells to secrete more insulin.

This article has been cited by other articles:

				K. Shinozaki, K. Ayajiki, Y. Nishio, T. Sugaya, A. Kashiwagi, and T. Okamura Evidence for a Causal Role of the Renin-Angiotensin System in Vascular Dysfunction Associated With Insulin Resistance Hypertension, February 1, 2004; 43(2): 255 - 262. [Abstract] [Full Text] [PDF]

				O. Gonzalez-Albarran and R. Garcia-Robles Correlation Between Insulin Suppression Test and Quantitative Insulin Sensitivity Check Index in Hypertensive and Normotensive Obese Patients Diabetes Care, November 1, 2001; 24(11): 1998 - 2000. [Full Text] [PDF]

				K. Shinozaki, Y. Nishio, T. Okamura, Y. Yoshida, H. Maegawa, H. Kojima, M. Masada, N. Toda, R. Kikkawa, and A. Kashiwagi Oral Administration of Tetrahydrobiopterin Prevents Endothelial Dysfunction and Vascular Oxidative Stress in the Aortas of Insulin-Resistant Rats Circ. Res., September 29, 2000; 87(7): 566 - 573. [Abstract] [Full Text] [PDF]

				M. Suzuki, Y. Kimura, M. Tsushima, and Y. Harano Association of Insulin Resistance With Salt Sensitivity and Nocturnal Fall of Blood Pressure Hypertension, April 1, 2000; 35(4): 864 - 868. [Abstract] [Full Text] [PDF]

				A. Kashiwagi, K. Shinozaki, Y. Nishio, H. Maegawa, Y. Maeno, A. Kanazawa, H. Kojima, M. Haneda, H. Hidaka, H. Yasuda, et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E976 - E983. [Abstract] [Full Text] [PDF]

				M. Suzuki, K. Shinozaki, A. Kanazawa, Y. Hara, Y. Hattori, M. Tsushima, and Y. Harano Insulin Resistance as an Independent Risk Factor for Carotid Wall Thickening Hypertension, October 1, 1996; 28(4): 593 - 598. [Abstract] [Full Text]

				Y. Nagai, Y. Nishio, T. Nakamura, H. Maegawa, R. Kikkawa, and A. Kashiwagi Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1180 - E1190. [Abstract] [Full Text] [PDF]